Cardinal Healthvs.Cencora
CAH vs COR · both in Distribution & pharmacy infrastructure, part of the Medicine, pharma & life science value chain: Wholesalers, distribution and pharmacy chains that get medicines to patients.
Cardinal Health and Cencora are similar in size by market cap; Cencora trades at the lower P/E (23.2 vs 35.5); year to date, Cardinal Health leads (+14.7% vs −10.2%).
Side by side
| CAH | COR | |
|---|---|---|
| Market cap | $55.2B | $59.2B |
| Price | $235.80 | $303.44 |
| Today | +0.9% | +0.3% |
| Return YTD | +14.7% | −10.2% |
| Return 1Y | +45.4% | +2.1% |
| P/E | 35.5 | 23.2 |
| P/S | 0.2 | 0.2 |
| P/B | 55.3 | 17.4 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Cardinal HealthCAH
American pharmaceutical wholesaler and medical products supplier — distributes medicines and manufactures medical consumables.
Full CAH profile →CencoraCOR
American pharmaceutical wholesaler (formerly AmerisourceBergen) — distributes medicines and specialty drugs to the healthcare sector.
Full COR profile →More comparisons in Distribution & pharmacy infrastructure
See where CAH and COR sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →